Free Trial

Sapience Investments LLC Sells 40,420 Shares of National Vision Holdings, Inc. (NASDAQ:EYE)

National Vision logo with Consumer Staples background

Sapience Investments LLC trimmed its stake in National Vision Holdings, Inc. (NASDAQ:EYE - Free Report) by 15.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 218,456 shares of the company's stock after selling 40,420 shares during the quarter. Sapience Investments LLC owned about 0.28% of National Vision worth $2,276,000 as of its most recent SEC filing.

Several other institutional investors have also recently bought and sold shares of EYE. SG Capital Management LLC acquired a new position in shares of National Vision during the fourth quarter valued at about $11,827,000. Point72 Asset Management L.P. acquired a new position in shares of National Vision during the fourth quarter valued at about $860,000. Polar Asset Management Partners Inc. acquired a new position in shares of National Vision during the fourth quarter valued at about $2,264,000. Prentice Capital Management LP purchased a new position in National Vision during the fourth quarter worth about $200,000. Finally, ProShare Advisors LLC boosted its holdings in National Vision by 44.4% during the fourth quarter. ProShare Advisors LLC now owns 23,480 shares of the company's stock worth $245,000 after purchasing an additional 7,221 shares during the last quarter.

Insider Activity

In other National Vision news, SVP Ravi Acharya sold 12,000 shares of the stock in a transaction that occurred on Tuesday, May 13th. The shares were sold at an average price of $18.75, for a total value of $225,000.00. Following the sale, the senior vice president now directly owns 11,700 shares in the company, valued at $219,375. This represents a 50.63% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 2.70% of the stock is owned by company insiders.

National Vision Stock Performance

Shares of EYE stock traded up $0.16 during trading on Tuesday, reaching $19.38. 2,348,951 shares of the company's stock traded hands, compared to its average volume of 1,796,711. The company has a market capitalization of $1.53 billion, a P/E ratio of -96.90, a PEG ratio of 3.27 and a beta of 1.02. The company has a current ratio of 0.57, a quick ratio of 0.37 and a debt-to-equity ratio of 0.30. The firm's 50-day moving average is $13.25 and its 200 day moving average is $12.11. National Vision Holdings, Inc. has a 1 year low of $9.56 and a 1 year high of $19.49.

National Vision (NASDAQ:EYE - Get Free Report) last announced its quarterly earnings results on Wednesday, May 7th. The company reported $0.34 EPS for the quarter, beating analysts' consensus estimates of $0.32 by $0.02. The company had revenue of $510.32 million for the quarter, compared to analysts' expectations of $510.30 million. National Vision had a negative net margin of 0.81% and a positive return on equity of 3.52%. National Vision's revenue was up 5.7% compared to the same quarter last year. During the same period in the prior year, the company posted $0.32 EPS. Equities research analysts expect that National Vision Holdings, Inc. will post 0.31 EPS for the current year.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on EYE. Loop Capital boosted their price target on shares of National Vision from $18.00 to $20.00 and gave the stock a "buy" rating in a report on Thursday, May 8th. The Goldman Sachs Group boosted their price target on shares of National Vision from $13.00 to $17.00 and gave the stock a "neutral" rating in a report on Friday, May 9th. Morgan Stanley cut their price target on shares of National Vision from $14.00 to $13.00 and set an "equal weight" rating on the stock in a report on Tuesday, January 21st. Citigroup upgraded shares of National Vision from a "neutral" rating to a "buy" rating and boosted their price target for the stock from $13.00 to $21.00 in a report on Friday, May 9th. Finally, UBS Group boosted their price target on shares of National Vision from $18.00 to $20.00 and gave the stock a "buy" rating in a report on Thursday, May 8th. Five analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of "Hold" and a consensus price target of $17.75.

Read Our Latest Stock Report on EYE

National Vision Company Profile

(Free Report)

National Vision Holdings, Inc, through its subsidiaries, operates as an optical retailer in the United States. The company operates in two segments, Owned & Host and Legacy. It offers eyeglasses and contact lenses, and optical accessory products; provides eye exams through its America's Best, Eyeglass World, Vista Optical, Fred Meyer, and Vista Optical military, as well as Vision Center branded stores; and offers health maintenance organization and optometric services.

Recommended Stories

Institutional Ownership by Quarter for National Vision (NASDAQ:EYE)

Should You Invest $1,000 in National Vision Right Now?

Before you consider National Vision, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Vision wasn't on the list.

While National Vision currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Magnificent 7 Stocks Shift Toward Stability and Selective Growth
4 Biotech Stocks on the Verge of Massive Breakthroughs
New AI Deals Just Sent These 4 Infrastructure Stocks Soaring

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines